227 related articles for article (PubMed ID: 20516069)
1. The cdk5 kinase regulates the STAT3 transcription factor to prevent DNA damage upon topoisomerase I inhibition.
Courapied S; Sellier H; de Carné Trécesson S; Vigneron A; Bernard AC; Gamelin E; Barré B; Coqueret O
J Biol Chem; 2010 Aug; 285(35):26765-26778. PubMed ID: 20516069
[TBL] [Abstract][Full Text] [Related]
2. The EGFR-STAT3 oncogenic pathway up-regulates the Eme1 endonuclease to reduce DNA damage after topoisomerase I inhibition.
Vigneron A; Gamelin E; Coqueret O
Cancer Res; 2008 Feb; 68(3):815-25. PubMed ID: 18245483
[TBL] [Abstract][Full Text] [Related]
3. Cyclin-dependent kinase 5 modulates STAT3 and androgen receptor activation through phosphorylation of Ser⁷²⁷ on STAT3 in prostate cancer cells.
Hsu FN; Chen MC; Lin KC; Peng YT; Li PC; Lin E; Chiang MC; Hsieh JT; Lin H
Am J Physiol Endocrinol Metab; 2013 Oct; 305(8):E975-86. PubMed ID: 23941877
[TBL] [Abstract][Full Text] [Related]
4. Cdk5 regulates STAT3 activation and cell proliferation in medullary thyroid carcinoma cells.
Lin H; Chen MC; Chiu CY; Song YM; Lin SY
J Biol Chem; 2007 Feb; 282(5):2776-84. PubMed ID: 17145757
[TBL] [Abstract][Full Text] [Related]
5. RET Regulates Human Medullary Thyroid Cancer Cell Proliferation through CDK5 and STAT3 Activation.
Yue CH; Oner M; Chiu CY; Chen MC; Teng CL; Wang HY; Hsieh JT; Lai CH; Lin H
Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34207842
[TBL] [Abstract][Full Text] [Related]
6. Gadd45a suppresses tumor angiogenesis via inhibition of the mTOR/STAT3 protein pathway.
Yang F; Zhang W; Li D; Zhan Q
J Biol Chem; 2013 Mar; 288(9):6552-60. PubMed ID: 23329839
[TBL] [Abstract][Full Text] [Related]
7. Targeting STAT3/miR-21 axis inhibits epithelial-mesenchymal transition via regulating CDK5 in head and neck squamous cell carcinoma.
Sun SS; Zhou X; Huang YY; Kong LP; Mei M; Guo WY; Zhao MH; Ren Y; Shen Q; Zhang L
Mol Cancer; 2015 Dec; 14():213. PubMed ID: 26690371
[TBL] [Abstract][Full Text] [Related]
8. Cyclin-dependent kinase 5 represses Foxp3 gene expression and Treg development through specific phosphorylation of Stat3 at Serine 727.
Lam E; Choi SH; Pareek TK; Kim BG; Letterio JJ
Mol Immunol; 2015 Oct; 67(2 Pt B):317-24. PubMed ID: 26198700
[TBL] [Abstract][Full Text] [Related]
9. Cdk5 links with DNA damage response and cancer.
Liu W; Li J; Song YS; Li Y; Jia YH; Zhao HD
Mol Cancer; 2017 Mar; 16(1):60. PubMed ID: 28288624
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylation of a splice variant of collapsin response mediator protein 2 in the nucleus of tumour cells links cyclin dependent kinase-5 to oncogenesis.
Grant NJ; Coates PJ; Woods YL; Bray SE; Morrice NA; Hastie CJ; Lamont DJ; Carey FA; Sutherland C
BMC Cancer; 2015 Nov; 15():885. PubMed ID: 26555036
[TBL] [Abstract][Full Text] [Related]
11. Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex.
Hofland K; Petersen BO; Falck J; Helin K; Jensen PB; Sehested M
Clin Cancer Res; 2000 Apr; 6(4):1488-97. PubMed ID: 10778981
[TBL] [Abstract][Full Text] [Related]
12. CDK5-mediated phosphorylation of p19INK4d avoids DNA damage-induced neurodegeneration in mouse hippocampus and prevents loss of cognitive functions.
Ogara MF; Belluscio LM; de la Fuente V; Berardino BG; Sonzogni SV; Byk L; Marazita M; Cánepa ET
Biochim Biophys Acta; 2014 Jul; 1843(7):1309-24. PubMed ID: 24703879
[TBL] [Abstract][Full Text] [Related]
13. Methyleugenol and oxidative metabolites induce DNA damage and interact with human topoisomerases.
Groh IA; Rudakovski O; Gründken M; Schroeter A; Marko D; Esselen M
Arch Toxicol; 2016 Nov; 90(11):2809-2823. PubMed ID: 26542539
[TBL] [Abstract][Full Text] [Related]
14. Regulation of cyclin-dependent kinase 5 and p53 by ERK1/2 pathway in the DNA damage-induced neuronal death.
Lee JH; Kim KT
J Cell Physiol; 2007 Mar; 210(3):784-97. PubMed ID: 17117479
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylation of STAT3 by axonal Cdk5 promotes axonal regeneration by modulating mitochondrial activity.
Hwang J; Namgung U
Exp Neurol; 2021 Jan; 335():113511. PubMed ID: 33098871
[TBL] [Abstract][Full Text] [Related]
16. Mutations in the linker domain affect phospho-STAT3 function and suggest targets for interrupting STAT3 activity.
Mertens C; Haripal B; Klinge S; Darnell JE
Proc Natl Acad Sci U S A; 2015 Dec; 112(48):14811-6. PubMed ID: 26553978
[TBL] [Abstract][Full Text] [Related]
17. STAT3 regulated ATR via microRNA-383 to control DNA damage to affect apoptosis in A431 cells.
Liao XH; Zheng L; He HP; Zheng DL; Wei ZQ; Wang N; Dong J; Ma WJ; Zhang TC
Cell Signal; 2015 Nov; 27(11):2285-95. PubMed ID: 26261078
[TBL] [Abstract][Full Text] [Related]
18. Study of ATM Phosphorylation by Cdk5 in Neuronal Cells.
She H; Mao Z
Methods Mol Biol; 2017; 1599():363-374. PubMed ID: 28477132
[TBL] [Abstract][Full Text] [Related]
19. CDK5 Activates Hippo Signaling to Confer Resistance to Radiation Therapy Via Upregulating TAZ in Lung Cancer.
Zeng Y; Liu Q; Wang Y; Tian C; Yang Q; Zhao Y; Liu L; Wu G; Xu S
Int J Radiat Oncol Biol Phys; 2020 Nov; 108(3):758-769. PubMed ID: 32407930
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-26a/cyclin-dependent kinase 5 axis controls proliferation, apoptosis and in vivo tumor growth of diffuse large B-cell lymphoma cell lines.
Farina FM; Inguscio A; Kunderfranco P; Cortesi A; Elia L; Quintavalle M
Cell Death Dis; 2017 Jun; 8(6):e2890. PubMed ID: 28640256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
